Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Iisager

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Reviews. Urology|January 9, 2025
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinomaJesper Jespersen, Cecilie Lindgaard, Laura Iisager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2023
Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the ClinicIben Lyskjær, Laura Iisager, Christian Tang Axelsen, et al.
Acta Oncologica (Stockholm, Sweden)|February 23, 2024
KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer - an observational trial. Study protocolLaura Iisager, Johanne Ahrenfeldt, Anna Krarup Keller, et al.
BMC Cancer|February 24, 2024
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-TrialLaura Iisager, Johanne Ahrenfeldt, Frede Donskov, et al.
Radiology|March 3, 2026
Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry StudyJohanne Ahrenfeldt, Jesper Jespersen, Pernille Tonnesen, et al.
European Journal of Epidemiology|May 14, 2025
Trends in kidney cancer: exploring the impact of sex and age on stage of disease, and prognosis during the past three decades in Denmark-a DaRenCa studyJohanne Ahrenfeldt, Jesper Jespersen, Jens Ejrnæs Lyngstrand, et al.
British Journal of Cancer|April 10, 2026
Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancerKaroline Kondrup, Laura Iisager, Paul Vinu Salachan, et al.
Clinical Epigenetics|January 22, 2026
Epigenomic subtypes and prognostic methylation signatures in clear cell renal cell carcinomaLaura Iisager, Cecilie Lindgaard, Johanne Ahrenfeldt, et al.
Nature Communications|November 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell typesLudvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Reviews. Urology|January 9, 2025
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinomaJesper Jespersen, Cecilie Lindgaard, Laura Iisager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2023
Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the ClinicIben Lyskjær, Laura Iisager, Christian Tang Axelsen, et al.
Acta Oncologica (Stockholm, Sweden)|February 23, 2024
KIDNEY-PAGER: analysis of circulating tumor DNA as a biomarker in renal cancer - an observational trial. Study protocolLaura Iisager, Johanne Ahrenfeldt, Anna Krarup Keller, et al.
BMC Cancer|February 24, 2024
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-TrialLaura Iisager, Johanne Ahrenfeldt, Frede Donskov, et al.
Radiology|March 3, 2026
Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry StudyJohanne Ahrenfeldt, Jesper Jespersen, Pernille Tonnesen, et al.
European Journal of Epidemiology|May 14, 2025
Trends in kidney cancer: exploring the impact of sex and age on stage of disease, and prognosis during the past three decades in Denmark-a DaRenCa studyJohanne Ahrenfeldt, Jesper Jespersen, Jens Ejrnæs Lyngstrand, et al.
British Journal of Cancer|April 10, 2026
Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancerKaroline Kondrup, Laura Iisager, Paul Vinu Salachan, et al.
Clinical Epigenetics|January 22, 2026
Epigenomic subtypes and prognostic methylation signatures in clear cell renal cell carcinomaLaura Iisager, Cecilie Lindgaard, Johanne Ahrenfeldt, et al.
Nature Communications|November 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell typesLudvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting, et al.
Pageof 1